Burlington-based LabCorp (NYSE: LH) has extended its offer for shares in Orchid Cellmark (Nasdaq: ORCH) through Nov. 15.

The most recent extension of the offer expired Nov. 4.

LabCorp is continuing to work with the FTC to receive regulatory approval for the deal.

Read the announcement here.

Get the latest news alerts: Follow WRAL Tech Wire at Twitter.